Natrol(R) Ester-C(R) 500 mg Receives Gold Medal Vity Award; Nationwide Survey of Health Food Retailers Names Natrol Ester-C 500 mg as Most Popular Product in the Vitamin C Category

Introduced in the 1990's by Vitamin Retailer Magazine, the VityAwards recognize the most popular products within the Health Foodindustry. Awards are given based upon results of a poll reachingthousands of retailers throughout the country.

Eric Schick, Vice President of Marketing for Natrol, stated, "Weare delighted to be recognized by vitamin and dietary supplementretailers as the `gold standard' brand of the Vitamin C category.Natrol was the first manufacturer to offer Ester-C products toretailers twenty years ago. Over the years, both retailers and theircustomers have trusted Natrol to provide premium-quality, innovativeand effective products such as Ester-C. We have never taken that trustfor granted. We are pleased that our retail partners continue torecognize the high standards of our products and the quality of lifethey bring to those who use them."

Natrol Ester-C is a non-acidic form of Vitamin C. Its patentedmanufacturing process neutralizes the pH, making Ester-C gentle on thedigestive system. Ester-C is available in a full range of potency(250-1000 mg) and forms, including tablets, capsules, soft chews,wafers, liquid and powder.

Ester-C(R) is a licensed trademark of Zila Nutraceuticals, Inc.

About Natrol

Founded in 1980, Natrol, Inc. (NASDAQ:NTOL) is a diversifiednutrition company that manufactures and markets premium-brandednutritional products, functional teas and sports fitness productsunder the Natrol(R), Laci Le Beau(R) Tea and Prolab(R) SportsNutrition labels. Natrol markets more than 200 nutritional productsdesigned to meet a wide range of consumer needs. The products areavailable at more than 54,000 food, drug, mass market and independenthealth food stores, catalogs and Internet sites, gyms and specialtystores nationally and in select foreign countries. For moreinformation, visit www.natrol.com.

The statements made in this press release which are not historicalfacts including statements regarding expectations for future growth ofrevenue and profits and trends concerning net sales, areforward-looking statements within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the SecuritiesExchange Act of 1934, as amended. As a result of a number of factors,the Company's actual results could differ materially from those setforth in the forward-looking statements. Certain factors that mightcause Natrol's actual results to differ materially from those setforth in the forward-looking statements include adverse trends in thedietary supplements industry, intense competition, adverse effects ofunfavorable publicity regarding particular products or the Company'sindustry generally, the Company's dependence on the introduction ofsuccessful new products, the Company's ability to gain market shareand shelf space in each of its distribution channels, the Companyexperiencing high rates of product returns, and adverse governmentregulation, as well as those factors set forth under the heading "RiskFactors" in the Company's Annual Report on Form 10-K for the yearended December 31, 2005 and in the Company's other filings withSecurities and Exchange Commission.